MicrobiologybioRxivPreprint
Validating Conditionally Essential Targets: Discovery of the First Orally Effective Biotin Inhibitor against MycobacteriumTuberculosis
Qiang Liu, Joshua B. Wallach, Yahani P. Jayasinghe…·Courtney C. Aldrich
The paper develops an orally effective biotin inhibitor, C48, against Mycobacterium tuberculosis, demonstrating in vivo efficacy in a low-biotin mouse model.
2 citations